Jove
Visualize
Contact Us

Related Experiment Videos

[Intraamniotic surfactant supply as RDS prevention].

Jacek Lisawa1, Dariusz Pietrasik, Jerzy Zwoliński

  • 1Klinika Połoznictwa i Ginekologii IMD, Instytut Matki i Dziecka w Warszawie.

Medycyna Wieku Rozwojowego
|November 13, 2004
PubMed
Summary

Antenatal steroids and postnatal surfactant are established treatments for respiratory distress syndrome (RDS). Intra-amniotic surfactant, administered before birth, shows promise for RDS prevention with no observed complications in this preliminary study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neonatal outcomes for women diagnosed with cancer during pregnancy - single-center study.

Ginekologia polska·2023
Same author

Comparative Genomic Hybridization to Microarrays in Fetuses with High-Risk Prenatal Indications: Polish Experience with 7400 Pregnancies.

Genes·2022
Same author

MaterCare International in Mission.

The Linacre quarterly·2021
Same author

Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women.

International journal of environmental research and public health·2018
Same author

[Serum concentrations of visfatin and oxidative stress markers in tobacco smoking pregnant women].

Przeglad lekarski·2018
Same author

[Umbilical cord serum hepcidin levels and maternal smoking during pregnancy].

Przeglad lekarski·2016
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Obstetrics

Context:

  • Respiratory Distress Syndrome (RDS) is a significant cause of neonatal morbidity and mortality.
  • Antenatal corticosteroids and postnatal surfactant therapy are current standards of care but have limitations.
  • Novel strategies for RDS prevention are actively being researched.

Purpose:

  • To evaluate the safety and efficacy of intra-amniotic surfactant administration for preventing RDS.
  • To assess the feasibility of delivering surfactant directly into the amniotic cavity prior to delivery.
  • To investigate the role of provoking fetal breathing movements before surfactant instillation.

Summary:

  • Natural surfactant was administered intra-amniotically to 15 pregnant women between 24-32 weeks gestation, prior to scheduled delivery.

Related Experiment Videos

  • Ultrasound guidance was used for surfactant instillation near the fetal airway; Aminophylline was given to stimulate fetal breathing.
  • No procedural complications were noted, and newborns showed reduced severe asphyxia and no need for postpartum surfactant therapy.

    • Impact:

    • Intra-amniotic surfactant instillation appears to be a safe and potentially effective method for RDS prevention.
    • Preliminary results suggest a favorable outcome for newborns, with a high survival rate and reduced need for mechanical ventilation.
    • Further research with larger cohorts is warranted to confirm these encouraging findings and establish clinical utility.